MetLife Investment Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,364
| Closed | -$574K | – | 2355 |
|
|
2020
Q4 | $574K | Sell |
4,364
-1,212
| -22% | -$159K | 0.01% | 1420 |
|
|
2020
Q3 | $282K | Hold |
5,576
| – | – | ﹤0.01% | 1659 |
|
|
2020
Q2 | $266K | Hold |
5,576
| – | – | ﹤0.01% | 1733 |
|
|
2020
Q1 | $273K | Hold |
5,576
| – | – | ﹤0.01% | 1523 |
|
|
2019
Q4 | $320K | Hold |
5,576
| – | – | ﹤0.01% | 1703 |
|
|
2019
Q3 | $201K | Sell |
5,576
-2,877
| -34% | -$103K | ﹤0.01% | 1943 |
|
|
2019
Q2 | $263K | Hold |
8,453
| – | – | ﹤0.01% | 1871 |
|
|
2019
Q1 | $198K | Buy |
+8,453
| New | +$198K | ﹤0.01% | 1988 |
|